Skip to main content
HeartCited

Nattokinase के लिए Atherosclerosis

B

12-month RCT showed reduced carotid intima-media thickness progression. Fibrinolytic activity well-documented. Blood pressure reduction also demonstrated.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dnattokinase\u0026condition\u003Datherosclerosis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

निष्कर्ष

12-month RCT showed reduced carotid intima-media thickness progression. Fibrinolytic activity well-documented. Blood pressure reduction also demonstrated.

Key Statistics

4

अध्ययन

300

प्रतिभागी

Positive

B

ग्रेड

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
2,000 FU (fibrinolytic units)/day
cardiovascularsupport:
2,000-4,000 FU/day

अधिकतम सीमा: Not formally established; up to 10,800 FU/day used in clinical trials

सेवन का सर्वोत्तम समय: On empty stomach (between meals) for optimal fibrinolytic activity

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Generally well-tolerated
  • Increased bleeding risk (fibrinolytic activity)
  • Mild gastrointestinal discomfort
  • Bruising (rare)

ज्ञात अंतःक्रियाएँ

  • Anticoagulants — warfarin, DOACs (additive anticoagulant effects — contraindicated)
  • Antiplatelet drugs (additive bleeding risk)
  • NSAIDs (increased bleeding risk)
  • Fish oil at high doses (additive anticoagulant effect)

सहनीय अधिकतम सेवन: Not formally established; up to 10,800 FU/day used in clinical trials

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Nattokinase help with Atherosclerosis?
Based on 4 studies with 300 participants, there is moderate evidence from clinical studies that Nattokinase may support Atherosclerosis management. Our evidence grade is B (Good Evidence).
How much Nattokinase should I take for Atherosclerosis?
Studies have used various dosages. A commonly studied range is 2,000 FU (fibrinolytic units)/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Nattokinase?
Reported side effects may include Generally well-tolerated, Increased bleeding risk (fibrinolytic activity), Mild gastrointestinal discomfort, Bruising (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Nattokinase and Atherosclerosis?
We rate the evidence as Grade B (Good Evidence). This rating is based on 4 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Atherosclerosis

Nattokinase अन्य स्वास्थ्य स्थितियों के लिए

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।